Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
Sorafenib Tosylate and Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01253070. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03634228. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
ClinicalTrials.gov study NCT01904136. IPD Sharing: Not stated. Countries: 1. Publications: 1.
OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03390296. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Donor Peripheral Stem Cell Transplant in Treating Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00274846. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targeted Therapies Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia (
ClinicalTrials.gov study NCT02677922. IPD Sharing: Not stated. Countries: 14. Publications: 4.
Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients
ClinicalTrials.gov study NCT00590187. IPD Sharing: NO. Countries: 1. Publications: 1.
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
ClinicalTrials.gov study NCT00136084. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed, Previously Untreated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00602771. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01786343. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pevonedistat and Belinostat in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03772925. IPD Sharing: YES. Countries: 1. Publications: 1.
Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00407966. IPD Sharing: Not stated. Countries: 1. Publications: 1.
KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04914845. IPD Sharing: NO. Countries: 1. Publications: 1.
Alvocidib, Cytarabine, and Mitoxantrone Hydrochloride or Cytarabine and Daunorubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01349972. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Biomarker-Directed Phase 2 Trial of Tamibarotene (SY-1425) in Participants With Acute Myeloid Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02807558. IPD Sharing: NO. Countries: 2. Publications: 1.
Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00313586. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ipilimumab and Decitabine in Treating Patients With Relapsed or Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT02890329. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Geriatric Assessment & Genetic Profiling to Personalize Therapy in Older Adults With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03226418. IPD Sharing: NO. Countries: 1. Publications: 3.
A Study of Cusatuzumab Plus Azacitidine in Participants With Newly Diagnosed Acute Myeloid Leukemia Who Are Not Candidates for Intensive Chemotherapy
ClinicalTrials.gov study NCT04023526. IPD Sharing: YES. Countries: 9. Publications: 1.
AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01253447. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.